Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Benefits of GLP-1 Agonists in MASH Histologic Improvements Studies have shown that treatment with GLP-1 agonists can lead to a reduction in liver inflammation and fibrosis, and hence result in an improvement in the overall structure of liver tissue1
OCTN1 (Yellow): Low-affinity carnitine transporter participates in carnitine transport in various tissues
Retatrutide's novel triple-agonist approach produced 28.7% weight loss in Phase 3 TRIUMPH-4 (confirming 24.2% in Phase 2) by adding glucagon and GIP recept
In clinical trials, Retatrutide showed significant promise, with early results suggesting it could offer greater weight loss than existing options like Wegovy and Zepbound
Reading time: 14 min Author Published on Updated on Weight loss Get expert guidance and a personalized care plan designed around you
The Danish drugmaker plans to launch Extensior, a lower-cost authorised version of Ozempic, in South Africa on 27 July through a partnership with Swiss healthcare company Acino
